New drug trial aims to calm esophagus inflammation
NCT ID NCT05485155
First seen Jan 07, 2026 · Last updated Apr 30, 2026 · Updated 18 times
Summary
This study tests whether Zemaira, a drug that blocks certain enzymes, can help adults with eosinophilic esophagitis (EoE), a condition where immune cells build up in the esophagus and cause trouble swallowing. Fifteen participants will receive Zemaira infusions weekly for 4 weeks. Researchers will measure changes in inflammation and track any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EOSINOPHILIC ESOPHAGITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The National Institutes of Health
RECRUITINGBethesda, Maryland, 20892, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.